Skip to main content

Table 1 Patient characteristics

From: Neutrophil-to-lymphocyte ratio is a prognostic marker in bladder cancer patients after radical cystectomy

  Total (n = 74) NLR < 2.38 NLR ≥ 2.38 p-value
Age
<65 years 32 (43.2 %) 24 (52.9 %) 8 (34.8 %) 0.324
≥65 years 42 (56.8 %) 27 (47.1 %) 15 (65.2 %)
Gender
Female 16 (21.6 %) 11 (21.6 %) 5 (21.7 %) 0.987
Male 58 (78.4 %) 40 (78.4 %) 18 (78.3 %)
ECOG-PS
0 68 (91.9 %) 48 (94.1 %) 20 (87.0 %) 0.270
≥1 6 (8.1 %) 3 (5.9 %) 3 (13.0 %)
Neoadjuvant Chemotherapy
No 64 (86.5 %) 45 (88.2 %) 19 (82.6 %) 0.847
Yes 10 (13.5 %) 6 (11.8 %) 4 (17.4 %)
Clinical T stage
≤2 38 (51.4 %) 26 (51.0 %) 12 (52.2 %) 0.924
≥3 36 (48.6 %) 25 (49.0 %) 11 (47.8 %)
Clinical Lymph Node Metastasis
No 70 (94.6 %) 48 (94.1 %) 22 (95.7 %) 0.633
Yes 4 (5.4 %) 3 (5.9 %) 1 (4.3 %)
Surgical Margin
Negative 68 (91.9 %) 45 (88.2 %) 23 (100.0 %) 0.097
Positive 6 (8.1 %) 6 (11.8 %) 0 (0.0 %)
Adjuvant chemotherapy
No 49 (66.2 %) 35 (68.6 %) 14 (60.9 %) 0.514
Yes 25 (33.8 %) 16 (31.4 %) 9 (39.1 %)
Pathological T stage
≤2 53 (71.6 %) 37 (72.5 %) 16 (69.6 %) 0.792
≥3 21 (28.4 %) 14 (27.5 %) 7 (30.4 %)
Pathological Lymph Node Metastasis
No 64 (86.5 %) 43 (84.3 %) 21 (91.3 %) 0.339
Yes 10 (13.5 %) 8 (15.7 %) 2 (8.7 %)
  1. ECOG-PS Eastern Cooperative Oncology Group performance status